
FIP_BPS
@fip_bps
FIP’s Board of Pharmaceutical Sciences sharing the latest news and views with scientists around the world.
ID: 1124323103243419648
https://www.fip.org/pharmaceutical-sciences-and-the-special-interest-groups-sigs 03-05-2019 14:41:31
770 Tweet
758 Followers
37 Following


A new method to target GTPase enzymes linked to cancer & neurodegenerative diseases has been discovered UC San Francisco, USA. Researchers tested K-Ras-targeting drugs on other mutated GTPases, revealing new drug-binding sites. Findings in @CellPressNewsl: bit.ly/3YjGl2j.

New strains of Acinetobacter baumannii, a top priority pathogen identified by World Health Organization (WHO) due to its role in multi-drug-resistant infections, have been engineered by University of Liverpool, UK, facilitating the development of medicines targeting this bacteria. More here: journals.asm.org/doi/10.1128/aa….

A kidney organoid-based proximal tubule-on-chip (OPTECs-on-Chip) that closely mimics in vivo renal physiology has been developed by a team Kyoto University, Japan. More in iScience journal: bit.ly/3NmkGAw


MED6-189, a compound inspired by marine sponge extracts, has demonstrated effectiveness against drug-sensitive & drug-resistant Plasmodium falciparum strains in vitro & in humanised mouse models, report UC Riverside & Yale School of Medicine, USA, in Science Magazine science.org/doi/10.1126/sc…

Monoclonal antibodies against Acinetobacter baumannii, a multi-resistant bacteria associated with hospital-acquired infections, have been developed using genetically engineered mice by researchers at Cambridge University, UK. More in Nature Communications: nature.com/articles/s4146….


An organic-solvent-free method for peptide encapsulation in poly(lactic-co-glycolic acid) microspheres has been found by researchers from University of Michigan, USA, to offer sustained in vitro peptide release for over 56 days. Read more in Nature Communications: doi.org/10.1016/j.jcon…

Optimising magnesium stearate content & low-shear mixing improves aerosolisation in carrier-based dry powder inhalers, establishing a correlation between rheological parameters & fine particle fraction. More in the International Journal of Pharmaceutics: sciencedirect.com/science/articl…

A personalised dietary programme can significantly improve aspects of cardiometabolic health compared to standard dietary advice, according to a randomised clinical trial conducted by the King's College London, UK. More in Nature Medicine: nature.com/articles/s4159…

Personalised brain circuit scores reveal six biotypes in depression and anxiety according to a study by Stanford Medicine, USA. These biotypes predict symptoms, behaviour & treatment response, paving the way for precision psychiatry. More in Nature Medicine: nature.com/articles/s4159…

FIP’s Pediatric Formulations Focus Group study on paediatric compounding was featured in Hospital Pharmacy Europe last week: bit.ly/3WsQSHf. Lead author & focus group chair Hala Fadda discusses off-label prescribing in paediatrics, & the study’s findings & recommendations.

A blood-first assay screening trial found entrectinib equally effective in advanced/metastatic non-small cell lung cancer patients diagnosed by liquid biopsy or tissue testing, achieving an 81.5% response rate. More in Nature Medicine: nature.com/articles/s4159…

Giovanni Pauletti, Pharmaceutical Science at FIP chair, shares his vision for strengthening pharmaceutical sciences & empowering the next generation of scientists to drive innovation.📖Read the full interview in this month’s International Pharmacy Journal (IPJ): fip.org/publications?i….


"Pharmacy practice research is the key to advancing global health," says Victoria Cardenas, Chair of the FIP Pharmacy Practice Research SIG. Read the full interview in the BPS newsletter – available in the FIP Library: fip.org/publications?p….


